MPEG1/perforin-2 mutations in human pulmonary nontuberculous mycobacterial infections
-
- Ryan M. McCormack
- Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, Florida, USA.
-
- Eva P. Szymanski
- Laboratory of Clinical Infectious Diseases, NIAID, NIH,
-
- Amy P. Hsu
- Laboratory of Clinical Infectious Diseases, NIAID, NIH,
-
- Elena Perez
- Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, Florida, USA.
-
- Kenneth N. Olivier
- Cardiovascular and Pulmonary Branch, NHLBI, NIH, Bethesda, Maryland, USA.
-
- Eva Fisher
- Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, Florida, USA.
-
- E. Brook Goodhew
- Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, Florida, USA.
-
- Eckhard R. Podack
- Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, Florida, USA.
-
- Steven M. Holland
- Laboratory of Clinical Infectious Diseases, NIAID, NIH,
書誌事項
- 公開日
- 2017-04-20
- DOI
-
- 10.1172/jci.insight.89635
- 公開者
- American Society for Clinical Investigation
説明
<jats:p> Perforin-2 is a highly conserved pore-forming protein encoded by macrophage expressed gene 1 ( <jats:italic>MPEG1</jats:italic> ). A number of studies have shown that Perforin-2–deficient mice are unable to survive following a bacterial challenge that is nonlethal in WT mice. There is also recent evidence that <jats:italic>Mpeg1</jats:italic> <jats:sup>+/–</jats:sup> heterozygous mice display an intermediate killing ability compared with <jats:italic>Mpeg1</jats:italic> WT and <jats:italic>Mpeg1</jats:italic> <jats:sup>–/–</jats:sup> mice. Despite these in vivo findings, to date, no perforin-2 deficiencies have been associated with human disease. Here, we report four patients with persistent nontuberculous mycobacterial infection who had heterozygous <jats:italic>MPEG1</jats:italic> mutations. In vitro, neutrophils, macrophages, and B cells from these patients were unable to kill <jats:italic>Mycobacterium avium</jats:italic> as efficiently as normal controls. CRISPR mutagenesis validated the deleterious antibacterial activity of these mutations. These data suggest that perforin-2 haploinsufficiency may contribute to human susceptibility to infections with intracellular bacteria. </jats:p>
収録刊行物
-
- JCI Insight
-
JCI Insight 2 (8), e89635-, 2017-04-20
American Society for Clinical Investigation